Andrew Jallouk

Hematology/Oncology Fellow at @MDAndersonNews | Interested in heme malignancies, cellular therapies, new technologies | Tweets and views are my own

[Hima Atluri, MD @HimaglobinA]

Honored to be selected for a @ConquerCancerFd Young Investigator Award for our project looking at the clonal hierarchy of WT1 mutations in AML! Grateful to my incredible mentors Dr. @sanamloghavi and Dr. Courtney DiNardo @MDAndersonNews for all of their support!

[Andrew Jallouk @AndrewJallouk]

@HimaglobinA @AaronGoodman33 @FasaAgbedia Could also just be an extensive lung cancer - bronchoalveolar carcinoma or lymphangitic spread. Definitely needs a chest CT.

[Chijioke Nze MD, MPH @chijioke_nze]

Awesome presentation of Phase II study w/ Pembro+Romidepsin in RR T-cell lymphoma by esteemed co-fellow Dr. @FasaAgbedia and fellow #Lymphoma enthusiast. Advancing the fight to #EndCancer. Kudos to @DrSwami_Iyer and the amazing @MDAndersonNews team. @ASH_hematology #ASH2022

[Andrew Jallouk @AndrewJallouk]

@HusseinAbbas01 @LeukemiaRF @MDAndersonNews Congrats Hussein! Well-deserved.

[Vincent Rajkumar @VincentRK]

My thoughts on the DETERMINATION trial in myeloma presented in the Plenary session of #ASCO22 and published simultaneously in @NEJM #ASCO22VR

1) This is not a trial of transplant vs no transplant.

2) It's ~ the 5th RCT of early vs delayed transplant

[Andrew Jallouk @AndrewJallouk]

Honored to be selected for a Young Investigator Award from @ConquerCancerFd and grateful for my fantastic mentors: @pbachi, Sattva Neelapu and Paolo Strati!
@MDAndersonNews